美年健康拟发行股份购买多家公司股权 发行价为4.74元

Core Viewpoint - Meinian Health plans to acquire stakes in multiple health examination companies through a share issuance, aiming to enhance its market position and service network in the health management sector [1][4][6] Group 1: Acquisition Details - Meinian Health intends to purchase 84% of Hengyang Meinian, 81% of Ningde Meinian, 75% of Yantai Meinian, and several other stakes in various health management companies [2][4] - The transaction will be executed via the issuance of A-shares at a price of 4.74 RMB per share, which is not less than 80% of the average trading price over the previous 120 trading days [4] Group 2: Business Impact - Upon completion of the transaction, Meinian Health will hold 100% of several health examination companies, significantly expanding its business scale and market share in the health examination service sector [4][6] - The acquisition is expected to strengthen the company's position in the health management market, allowing it to capitalize on industry growth opportunities and optimize its service network [6] Group 3: Transaction Structure - The transaction involves related parties, including a company controlled by the actual controller of Meinian Health, thus constituting a related party transaction [5] - The final transaction price will be determined after the completion of auditing and evaluation of the target companies [4]